IRadimed Corporation IRMD
NASDAQ
| 09/30/2026 | 06/30/2026 | 03/31/2026 | 12/31/2025 | 09/30/2025 | |
|---|---|---|---|---|---|
| Net Income | 13.21% | 11.61% | 19.34% | 16.88% | 13.73% |
| Total Depreciation and Amortization | 69.12% | 104.92% | 81.54% | 42.51% | 18.35% |
| Total Amortization of Deferred Charges | -- | -- | -- | -- | -- |
| Total Other Non-Cash Items | 66.82% | 71.96% | 353.79% | 209.91% | 59.04% |
| Change in Net Operating Assets | -1,829.09% | -197.61% | -133.55% | -215.86% | -108.40% |
| Cash from Operations | 8.55% | -0.01% | 11.19% | -2.64% | 6.21% |
| Capital Expenditure | 90.14% | 84.38% | 60.89% | 3.00% | -78.55% |
| Sale of Property, Plant, and Equipment | -- | -- | -- | -- | -- |
| Cash Acquisitions | -- | -- | -- | -- | -- |
| Divestitures | -- | -- | -- | -- | -- |
| Other Investing Activities | 34.04% | 34.70% | 39.04% | 19.19% | -23.94% |
| Cash from Investing | 86.07% | 81.23% | 59.42% | 4.49% | -73.03% |
| Total Debt Issued | -- | -- | -- | -- | -- |
| Total Debt Repaid | -- | -- | -- | -- | -- |
| Issuance of Common Stock | -- | -- | -- | -- | -85.12% |
| Repurchase of Common Stock | -234.34% | -241.04% | -237.19% | -272.32% | -35.79% |
| Issuance of Preferred Stock | -- | -- | -- | -- | -- |
| Repurchase of Preferred Stock | -- | -- | -- | -- | -- |
| Total Dividends Paid | -93.46% | -94.85% | -96.29% | -9.97% | 28.78% |
| Other Financing Activities | -- | -- | -- | -- | -- |
| Cash from Financing | -106.08% | -108.14% | -109.11% | -22.78% | 24.92% |
| Foreign Exchange rate Adjustments | -- | -- | -- | -- | -- |
| Miscellaneous Cash Flow Adjustments | -- | -- | -100.00% | -100.00% | -- |
| Net Change in Cash | 40.72% | 36.38% | 16.11% | -143.50% | -3.43% |